Global Antinuclear Antibody Test Market Trends and Industry Analysis Report 2018Antinuclear Antibody Test Market Trends and Industry Analysis Report 2018
The global Antinuclear Antibody Test Market is expected to reach USD 1,476.1 Million, at a CAGR of 12.4%.
(EMAILWIRE.COM, December 14, 2018 ) According to the new market research report “Antinuclear Antibody Test Market by Product (Reagents & Assay Kits, Systems, Software, Services), Technique (Immunofluorescence, Elisa, Multiplex), Disease (Rheumatoid Arthritis, SLE), End User (Clinical Labs, Hospitals) — Forecast to 2021”, published by MarketsandMarkets™.
The research report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the ANA testing market, along with revenue estimates & forecasts and market share analysis.
Ask For Discount: https://www.marketsandmarkets.com/discountreports.asp?id=218189007.
The increasing prevalence of autoimmune diseases and increasing healthcare expenditure worldwide are the major factors driving the growth of this market.
ANA Testing Instrument Manufacturers and Suppliers;
- Clinical Laboratories
- Hospitals
- Pharmaceutical and Biotechnology Companies
- Academic Research Institutes Related to Antinuclear Antibody
- Testing
Browse and in-depth TOC on “Antinuclear Antibody Test Market”
73 — Tables
102 — Figures
166 — Pages
View more detailed TOC @
https://www.marketsandmarkets.com/Market-Reports/antinuclear-antibody-test-market-218189007.html
Based on techniques, the Antinuclear Antibody Test Market is segmented into three broad segment, namely, enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay (IFA), and multiplex assay. The ELISA segment is expected to account for the largest share of this market owing to expanding applications of ANA in autoimmune disease testing and therapeutic drug level monitoring.
The Global antinuclear antibody test market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America will continue to dominate the global market in the forecast period. However, Asia is expected to witness the highest growth in the coming years, with the growth in this regional segment centered at China, Japan, and India.
Request Bundle of Adjacents Research Report: https://www.marketsandmarkets.com/FreeWorkshop.asp?id=218189007
Key players in the Antinuclear Antibody Test Market include Alere Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), ERBA Diagnostics, Inc. (U.S.), Trinity Biotech plc (Ireland), Thermo Fisher Scientific, Inc. (U.S.), Antibodies, Inc. (U.S.), EUROIMMUN AG (Germany), Immuno Concepts (U.S.), Inova Diagnostics (U.S.), and Zeus Scientific, Inc. (U.S.).
Media Contact
- Mr. Shelly Singh
- sales@marketsandmarkets.com